Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- Executive & Leadership Coaching
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Sustainability Consulting
- Transaction Advisory
- Trust & Estate
- Valuation
Noncompete litigation and lost profits claims may depend on unsupported assumptions. See how Weaver clarified financial, regulatory and market realities.
A shift in Affordable Care Act (ACA) exchange volume could reshape payer mix and earnings. Explore the health care valuation implications.
The SBIR and STTR reauthorization brings larger awards, stricter eligibility and more competition for life sciences companies seeking federal funding.
Published by Medical Journal–Houston, Jerod Holloway examines how enterprise risk management is evolving across health care organization.
Shifting imaging volumes and competitive pressure challenged a hospital. Learn how our valuation analysis helped the hospital plan for a joint venture.
Four interested buyers. Operational and financial hurdles. A new ambulatory surgery center at a crossroads. Learn how Weaver guided valuation strategy.
Published by Medical Journal-Houston, Weaver's Corey Palasota explains the real reason behind how Houston's health care provider landscape has shifted in the past year.
Explore practical insight for women pursuing board leadership, including executive presence and other skills that support confident performance.
A practical guide to governmental debt types, refundings and reporting risks. How to avoid common audit findings and compliance issues.
Explore regulatory drivers, private equity consolidation and emerging trends influencing health care valuation today.
Texas life sciences in 2025 saw concentrated capital, declining innovation output and earlier‑stage clinical shifts shaping the ecosystem.
HHS has adopted 2 CFR 200 and issued new implementation guidance at 2 CFR 300, replacing 45 CFR 75. Learn how the revised policy affects recipients.